DiaMedica Therapeutics Income Statement (2018-2019) | DMAC

Income Statement Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019
Revenue & cost
Revenue 0.50M
Operating items
Research & Development 0.79M1.07M1.21M1.45M2.61M1.87M1.62M1.80M
Selling, General & Administrative 0.52M0.78M0.78M0.67M0.81M0.87M1.04M0.97M
Operating Expenses 1.31M1.85M1.99M2.12M3.42M2.74M2.66M2.77M
Operating Income -1.31M-1.85M-1.49M-2.12M-3.42M-2.74M-2.66M-2.77M
EBIT -1.31M-1.85M-1.49M-2.12M-3.42M-2.74M-2.66M-2.77M
Non-operating items
Other Non Operating Income -0.04M0.01M-0.04M-0.01M0.00M0.05M-0.04M0.10M
Non Operating Income 0.66M0.13M0.16M0.16M-0.18M-0.28M0.23M0.29M
Net income details
EBT -0.65M-1.72M-1.33M-1.96M-3.24M-2.46M-2.44M-2.48M
Tax Provisions 0.00M0.02M0.06M0.01M0.01M0.01M0.01M0.00M
Profit After Tax -0.65M-1.74M-1.39M-1.96M-3.25M-2.47M-2.45M-2.48M
Income from Continuing Operations -0.65M-1.74M-1.39M-1.96M-3.25M-2.47M-2.45M-2.48M
Consolidated Net Income -0.65M-1.74M-1.39M-1.96M-3.25M-2.47M-2.45M-2.48M
Income towards Parent Company -0.65M-1.74M-1.39M-1.96M-3.25M-2.47M-2.45M-2.48M
Net Income towards Common Stockholders -0.65M-1.74M-1.39M-1.96M-3.25M-2.47M-2.45M-2.48M
Additional items
EPS (Basic) -0.10-0.22-0.18-0.23-0.27-0.21-0.20-0.21
Shares Outstanding (Weighted Average) 11.84M11.84M11.84M11.96M11.96M12.01M12.01M14.14M
EBITDA -0.65M-1.74M-1.39M-1.96M-3.25M-2.46M-2.45M-2.48M